PorOsteon received 510(k) clearance from the U.S. Food and Drug Administration to market its new Phusion Metal Cervical Cage.
The device is designed to maximize bone growth through a fully interconnected porous structure and matching the modulus of living cancellous bone. It is indicated for intervertebral body fusion of the spine in adult patients. The cervical cage is the first of a family of surgical devices taking advantage of the unique properties of Phusion Metal.
PorOsteon is a privately-held company focused on developing its proprietary Nitinol-based Phusion Metal for a wide range of musculoskeletal indications.
More articles on devices:
Inside orthopedic, spine device companies — 3 stock transactions
Benvenue Medical names Rick Simmons VP of sales & marketing
Dr. Daniel Le is uses 1st HipSextant Navigation system in Houston